Clinical Outcome for Chemoradiotherapy in Carcinoma of the Cervix

Clinical Oncology

Volumn 21, Issue 1, 2009, Pages 49-55

  Spensley, S ^a   Hunter, R D ^a   Livsey, J E ^a   Swindell, R ^a   Davidson, S E ^a  

^a CHRISTIE HOSPITAL   (United Kingdom)

Author keywords

Cervix carcinoma; chemoradiotherapy; outcome; survival; toxicity

Indexed keywords

CISPLATIN;

ADULT; AGED; ARTICLE; BLADDER INJURY; BRACHYTHERAPY; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; COHORT ANALYSIS; COLON OBSTRUCTION; CONTROLLED STUDY; DISEASE FREE SURVIVAL; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FOLLOW UP; GASTROINTESTINAL TOXICITY; HUMAN; INTESTINE INJURY; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; MULTIPLE CYCLE TREATMENT; NEUTROPENIA; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RECTUM FISTULA; SURVIVAL RATE; TREATMENT OUTCOME; UNITED KINGDOM; UNSPECIFIED SIDE EFFECT; UTERINE CERVIX CARCINOMA; UTERUS SURGERY;

ADULT; AGED; ANTINEOPLASTIC AGENTS; CARCINOMA; CISPLATIN; COMBINED MODALITY THERAPY; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MIDDLE AGED; NEOADJUVANT THERAPY; SURVIVAL RATE; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 58149166603     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clon.2008.10.014     Document Type: Article

References (29)

1. Pisani P., Parkin D.M., Bray F., and Ferlay J. Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer 83 (1999) 18-29
2. La Vecchia C., Lucchini F., Negri E., Boyle P., Maisonneuve P., and Levi F. Trends of cancer mortality in Europe, 1955-1989: III, breast and genital sites. Eur J Cancer 28A (1992) 927-998
3. Benadet J., Odicino F., Maisonneuve P., et al. FIGO 90-92, annual report. J Epidermiol Biostat 3 (1998) 1-34
4. NCI Clinical Announcement. Concurrent chemo-radiation for cervical cancer (Report). US Department of Public Health, February 1999.
5. Keys H.M., Bundy B.N., Stehman F.B., et al. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med 340 (1999) 1154-1161
6. Morris M., Eifel P.J., Lu J., et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high risk cervical cancer. N Engl J Med 340 (1999) 1137-1143
7. Rose P.G., Bundy B.N., Watkins E.B., et al. Concurrent cisplatinum based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 340 (1999) 1144-1153
8. Whitney C.W., Sause W., Bundy B.N., et al. Randomised comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynaecologic Oncology Group and Southwest Oncology Group study. J Clin Oncol 17 (1999) 1339-1348
9. Peters III W.A., Liu P.Y., Barrett R.J., et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high risk early stage cancer of the cervix. J Clin Oncol 18 (2000) 1606-1613
10. Denton A.S., Bond S.J., Matthews S., et al. National audit of the management and outcome of carcinoma of the cervix treated with radiotherapy in 1993. Clin Oncol 12 (2003) 347-353
11. Hunter R.D., Wong F., Moore C., et al. Bladder base dosage in patients undergoing intra-cavitary therapy. Radiother Oncol 7 (1986) 189-197
12. Chassagne D., Sismondi P., Horiot J.C., et al. A glossary for reporting complications of treatment in gynaecological cancers. Radiother Oncol 26 (1993) 195-202
13. Green J.A., Kirwan J.M., Tierney J.F., et al. Systematic review and meta-analysis of randomised trials of concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: better survival and reduced distant recurrence rate. Lancet 358 (2001) 781-786
14. Lukka H., Hirte H., Fyles A., et al. Concurrent cisplatin based chemotherapy plus radiotherapy for cervical cancer - a meta-analysis. Clin Oncol 14 (2002) 203-212
15. King M., McConkey C., Latief T., et al. Improved survival after concurrent weekly cisplatin and radiotherapy for cervical carcinoma with assessment of acute and late side effects. Clin Oncol 18 (2006) 38-45
16. Grigsby P.W., Mutch D.G., Rader J., et al. Lack of benefit of concurrent chemotherapy in patients with cervical cancer and negative lymph nodes by FDG-PET. Int J Radiat Oncol Biol Phys 61 2 (2005) 444-449
17. Singh A.K., Grigsby P.W., Dehdashti F., et al. FDG-PET lymph node staging and survival of patients with FIGO stage IIIB cervical carcinoma. Int J Radiat Oncol Biol Phys 56 2 (2003) 489-493
18. Loft A., Berthelsen A.K., Roed H., et al. The diagnostic value of PET/CT scanning in patients with cervical cancer: a prospective study. Gynecol Oncol 106 1 (2007) 29-34
19. Lai C.H., Yen T.C., and Chang T.C. Positron emission tomography imaging for gynaecological malignancy. Curr Opin Obstet Gynecol 19 1 (2007) 37-41
20. Symonds R.P., Habeshaw T., Reed N.S., et al. Scottish and Manchester randomised trial of neo-adjuvant chemotherapy for advanced cervical cancer. Eur J Cancer 36 (2003) 994-1001
21. Perez C.A., Grigsby P.W., Castro-Vita H., et al. Carcinoma of the uterine cervix. Impact of prolongation of overall treatment time and timing of brachytherapy on outcomes of radiation therapy. Int J Radiat Oncol Biol Phys 32 (1995) 1275-1288
22. Mackillop W.J., Bates J.H.T., O'Sullivan B., et al. The effect of delay in treatment on local control of radiotherapy. Int J Radiat Oncol Biol Phys 34 (1996) 243-250
23. Ang K.K., Trotti A., Brown B., et al. Randomised trial addressing risk features and time factors of surgery plus radiotherapy in advanced head and neck cancer. Int J Radiat Oncol Biol Phys 51 (2001) 571-578
24. Froud P.J., Mates D., Jackson J.S.H., et al. Effect of time interval between breast conserving surgery and radiation therapy on ipsilateral breast recurrence. Int J Radiat Oncol Biol Phys 46 (2000) 363-372
25. Martin J.M., Ryan G., and Duchesne G. Clinical prioritisation for curative radiotherapy: a local waiting list initiative. Clin Oncol 16 (2004) 299-306
26. Coles C.E., Burgess L., and Tan L.T. An audit of delays before and during radical radiotherapy for cervical cancer - effect on tumour cure probability. Clin Oncol 15 (2003) 47-54
27. Tan L.T., Russell S., and Burgess L. Acute toxicity of chemo-radiotherapy for cervical cancer: the Addenbrooke's experience. Clin Oncol 16 (2004) 255-260
28. Kirwan J.M., Symonds P., Green J.A., et al. A systematic review of acute and late toxicity of concomitant chemo-radiation for cervical cancer. [review]. Radiother Oncol 68 (2003) 217-226
29. Tan L.T., and Zahra M. Long term survival and late toxicity after chemo-radiotherapy for cervical cancer - the Addenbrooke's experience. Clin Oncol 20 (2008) 358-364